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Introduction: Our aim in this study was to present the results of sensory evaluation tests and
electrophysiological evaluations in rheumatoid arthritis (RA) patients with foot deformity
and  to determine their relation with general health status and lower extremity functionality.
Materials and methods: Fifty-one patients with RA diagnosis and foot deformity were included
in  the study. Demographic and disease characteristics of the patients were recorded, and a
detailed neurological examination was performed. Superﬁcial sensation, pain, heat, vibra-
tion,  and two-point discrimination sensation were evaluated in each foot, and their sum was
used to determine the sensory deﬁcits index (SDI) of 0–10. The presence of polyneuropathy
was  evaluated with electrophysiological methods. The Health Assessment Questionnaire
and  mobility and walking subscales of the Arthritis Impact Measurement Scales-2 were used
to  assess general health status and lower extremity functionality, respectively. According to
the  sensory examination and electromyography results, patients were compared in terms
of  their general health status and lower extremity functional status.
Results: Sensory disturbance was detected in 39 patients (74%) during the examination; how-
ever, 27 patients (52.9%) had polyneuropathy determined electrophysiologically. In patients
with sensory deﬁcits, statistically signiﬁcant deterioration was detected in general health
and foot functionality, including mobility and walking, when compared to patients with a
normal sensory evaluation.
Conclusions: Even in the presence of normal electrophysiological tests, sensory dysfunc-
tion alone seems to be associated with severe disability in general health status and footfunctionality when compared to patients with a normal sensory examination.
© 2015 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author.
E-mail: ebruumay@gmail.com (E. Karaca Umay).
ttp://dx.doi.org/10.1016/j.rbre.2015.08.010
255-5021/© 2015 Elsevier Editora Ltda. All rights reserved.
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Perturbac¸ões  sensitivas  e  polineuropatia  em  pacientes  com  artrite
reumatoide  com  deformidade  do  pé
Palavras-chave:
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Introduc¸ão: O objetivo deste estudo foi apresentar os resultados dos testes de avaliac¸ão
sensitiva e exame eletroﬁsiológico em pacientes com artrite reumatoide (AR) com deformi-
dade do pé e determinar a sua relac¸ão com o estado geral de saúde e aspecto funcional dos
membros inferiores.
Materiais e métodos: Foram incluídos no estudo 51 pacientes com diagnóstico de AR e
deformidade do pé. Foram registradas as características demográﬁcas e da doenc¸a de cada
indivíduo, e foi realizado um exame neurológico detalhado. Foi avaliada a sensibilidade
superﬁcial, sensibilidade dolorosa, sensibilidade térmica, sensibilidade vibratória e aplicado
o  teste de discriminac¸ão de dois pontos em cada um dos pés, e a soma dos escores foi usada
para determinar o índice de déﬁcits sensitivos (IDS) de 0-10. A presenc¸a de polineuropatia
foi avaliada com métodos eletroﬁsiológicos. Foi utilizado o Health Assessment Question-
naire e as subescalas mobilidade e deambulac¸ão da Arthritis Impact Measurement Scales-2
para avaliar o estado geral de saúde e o aspecto funcional de membros inferiores, respec-
tivamente. De acordo com os resultados dos exames de eletromiograﬁa e de sensibilidade,
os  pacientes foram comparados em relac¸ão ao seu estado geral de saúde e estado funcional
de  membros inferiores.
Resultados: Foram detectados distúrbios sensitivos em 39 pacientes (74%) durante o exame;
contudo, 27 deles (52,9%) tinham polineuropatia determinada eletroﬁsiologicamente. Em
pacientes com déﬁcits sensitivos, foi detectada deteriorac¸ão estatisticamente signiﬁca-
tiva no estado geral de saúde e no aspecto funcional do pé, inclusive na mobilidade e
deambulac¸ão,  quando comparados aos pacientes com uma avaliac¸ão sensitiva normal.
Conclusão: Mesmo na presenc¸a de testes eletroﬁsiológicos normais, a disfunc¸ão sensitiva
isolada parece estar associada a incapacidade grave no estado geral de saúde e no aspecto
funcional do pé em comparac¸ão a pacientes com um exame sensitivo normal.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Rheumatoid arthritis (RA) is a chronic, systemic and inﬂam-
matory disease with involvement of the peripheral joints,
and its etiology cannot be understood completely despite
the many  new developments. It causes joint destruction,
decreased life quality and shortened life expectancy.1
The joints of the hand are the most frequent and ini-
tially affected in arthritis; thus, studies in the literature have
focused mostly on hand deformities and hand disabilities.
While foot involvement at the onset of the disease has been
reported in 16–20% of patients, this ratio may increase to
approximately 95% over the course of the disease.2,3
Synovial hypertrophy and capsular tension generated by
hyperplasia, ligamentous laxity, muscular imbalance, and
ultimately joint subluxation and dislocation play a role in
the development of foot deformities in RA. Further, with the
direct effect of inﬂammation, destruction occurs in the carti-
lage and pericapsular structures.4 Due to all these changes, the
loading on joints causes different deformities and constitutes
a severe disability in the patient’s mobility and functional
5,6independence.
Nervous system involvement in RA is often in the
form of peripheral involvement.7 Entrapment neuropathies,
mononeuropathies, and sensory and sensorimotor axonalpolyneuropathies are considered in this context. In clinical
practice, superﬁcial touch, pain, heat, and vibration senses
with the two-point discrimination test, muscle strength mea-
surement, deep tendon reﬂexes tests, and electrophysiological
methods are used for the assessment of the peripheral ner-
vous system. Studies investigating the presence of neuropathy
in RA patients have frequently used electrophysiological
methods in their evaluations.7–10
Although sensory evaluation tests are often subjective
tests, in recent years, it is reported that the involvement of
the other nerve ﬁbers can be shown with these tests.11
While in some studies they were reported that a correla-
tion between deterioration in quality of life and functionality,
and foot complaints in RA,12,13 there is no study comparing
the sensory examination and electrophysiological assessment
ﬁndings or evaluating the relationship between these and the
patient’s general health status and lower extremity function-
ality.
Foot deformities in patients may be only visible part of the
iceberg and much more  its below. Even if effective treatment
was  given for the patient’s deformity, functionality and quality
of life may not be enough improvement due to nervous system
involvement.
We thus aimed in this study to present the results of the
electrophysiological evaluation and sensory evaluation tests
and to determine their relationship with lower extremity
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unctionality and general health status in RA patients with
oot deformity.
aterial  and  methods
tudy  population
his study was conducted by the Physical Medicine and Reha-
ilitation clinic in Ankara Diskapi Yildirim Beyazit Education
nd Research Hospital in Ankara, Turkey.
Fifty-one patients aged 35–65 years with foot deformity
nd diagnosed as RA according to the American College of
heumatology (ACR) 1990 classiﬁcation criteria were included
n this study.
Only housewives and female patients with no salaried
mployment were included because of foot involvement in RA
as reported as 89–90% in almost equal rates in both genders14
nd to ensure homogeneity in terms of functional status of
atients.
Exclusion criteria of the study were as follows: age under
6 years and over 65 years, male gender, lower extremity
rauma and/or history of operation, diabetes mellitus, acute
nd/or chronic liver and kidney disease, severe heart fail-
re, hypo/hyperthyroidism, amyloidosis, malignancy, vitamin
12 deﬁciency, additional connective tissue disease, such as
jögren’s syndrome, and/or vasculitis symptoms, previously
iagnosed peripheral nervous system involvement, and posi-
ive pathological reﬂexes. Also excluded from the study were
atients using more  than 7.5 mg  corticosteroid over the last
ix months or biologic therapy.
Our patients on biologic therapy represented late-period
isease and also ﬁt other exclusion criteria, such as mostly
igh-dose corticosteroid use and diabetes mellitus.
At baseline, patients were informed about the study and
heir written informed consent was obtained. The approval
f the hospital’s local ethics committee was received before
he study. The study was conducted in accordance with the
elsinki Declaration.
For the evaluation of demographic and disease characteris-
ics of the patients, age, education, marital status, duration of
he disease and of morning stiffness, medications used, num-
er of tender and swollen joints, quality of life (QOL) level,
rythrocyte sedimentation rate (ESR) (mm/h), and rheuma-
oid factor (RF) (IU/ml) were recorded. Disease activity score-28
DAS-28) was calculated by using tender and swollen joint
ounts, QOL level assessed on the visual analog scale of
–100 mm,  and ESR.
A detailed neurological examination of patients was
erformed. On the lower extremity sensory assessment,
uperﬁcial sensation, pain, heat, vibration, and two-point
iscrimination senses were evaluated in each foot, and with
he sum of these, the sensory deﬁcits index (SDI) of 0–10
as obtained. For superﬁcial senses, 5.07 Semmes-Weinstein
onoﬁlament was applied perpendicular to the plantar
urface of the distal phalanx of the foot thumb. Pain sen-
ation was evaluated with needle insertion into the plantar
urface of the distal phalanx of foot thumb. The patient was
ueried regarding distinction between blunt and sharp tip,
nd in the presence of correct answers to 8 of 10 questions, 6;5 6(3):191–197 193
pain sensation was accepted as preserved. Ice cubes were
applied for 3 s to the plantar surface of the distal phalanx
of foot thumb to determine heat sensation. Vibration sensa-
tion was evaluated on the dorsal surface of the metatarsal
joint of foot thumb with a 256 Hz tuning fork. Two-point
discrimination test was evaluated as static. Distance between
the two needles applied to the plantar side of the distal
phalanx of the foot thumb less than 0.5 cm was evaluated as
normal.
Electrophysiologic  tests
Polyneuropathy in patients was evaluated with Medelec Syn-
ergy 10-channel electroneuromyography (ENMG) (Oxford, U.K.)
device and the protocol described by Oh et al.15 Accordingly,
bilateral sural sensory nerve conduction studies and bilat-
eral peroneal and tibial nerve motor conduction studies were
carried out. For identiﬁcation of the polyneuropathy, right
median, ulnar motor and sensory nerve conduction studies
were added. Bilateral tibial and common peroneal nerve F
waves were studied. Entrapment neuropathy was ruled out
by applying the lateral and medial plantar nerve conduction
studies in patients without polyneuropathy. To identify the
presence of polyneuropathy, pathophysiological assessment
was performed as axonal or demyelinating at the affected
motor and sensory nerve ﬁber.
Clinic  tests
For the assessment of the functional status of patients, the
Health Assessment Questionnaire (HAQ) was used.16
Mobility and walking subscales of the Arthritis Impact Mea-
surement Scales-2 (AIMS-2) were used for assessing lower
extremity functionality.17 Scoring was from 0 to 10, with
0 indicating the best and 10 indicating the poorest health
status.
Comparisons
Patients were divided into groups according to SDI scores and
electrophysiological evaluation as SDI score 0 (group 1a), SDI
score ≥1 (group 1b), normal electrophysiological evaluation
(group 2a), and polyneuropathy (group 2b). Groups were com-
pared with HAQ in terms of their general health status and
with the mobility and gait subscales of AIMS-2 for the assess-
ment of their lower extremity functional status.
Statistical  analysis
For data analysis, the Statistical Package for the Social Sci-
ences 15.0 (SPSS Inc., USA) program was used. Descriptive
statistics were displayed with chi-square test for continuous
variables as mean ± standard deviation and median and for
nominal variables as a percentage. Shapiro–Wilk test was used
to examine whether the continuous variables were distributed
normally. Because there are non-normally distributed contin-
uous variables, the signiﬁcance of differences between the
groups with respect to the variables was investigated with
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Table 2 – The results of the sensory examination.
Right foot (n = 51)
n (%)
Left foot (n = 51)
n (%)
Sensory evaluation
Disturbance of superﬁcial
sensation
29 (56.9) 30 (58.8)
Disturbance of pain
sensation
14 (27.5) 14 (27.5)
Disturbance of
temperature sensation
13 (25.5) 13 (25.5)
Disturbance of vibration
sensation
34 (66.7) 34 (66.7)
Disturbance of two-point 16  (31.4) 15 (29.4)194  r e v b r a s r e u m a t
Mann–Whitney U-test. A value of p < 0.05 was considered sta-
tistically signiﬁcant.
Results
The average age of the 51 patients in the study was 54.0 years,
disease duration was 13 years, and morning stiffness dura-
tion was 30 min. The distribution of demographic and disease
characteristics of the patients are shown in Table 1.
The mean number of foot deformities was 8.00 (7.49 ± 4.24).
There were 17 patients (33.3%) with hammer toe, 15 (29.4%)
with claw toe, 25 (49%) with cock-up deformity, 32 (62.7%) with
hallux valgus, 21 (41.2%) with metatarsophalangeal subluxa-
tion, 11 (21.6%) with ankle contracture deformity, 29 (56.9%)
with pes planus, and 6 (11.8%) with pes cavus deformity.
The results of the sensory examination are presented in
Table 2.
Sensory disturbance was detected in 39 patients (76.4%).
The average level of SDI was found to be 4.00. Polyneuropathy
was detected in 27 patients (52.9%) with electrophysiologi-
cal evaluation. In all patients, there was sensorimotor axonal
polyneuropathy with sensorial predominance. At least one
sensory evaluation test was impaired in all patients.
Table 1 – The distribution of demographic and disease
characteristics of the patients.
n = 51
mean ± SD, n (%)
Age (year) 54.72 ± 10.98
Education level
Illiterate 10 (19.6)
Only literate 12 (23.5)
Primary school graduate 24 (47.1)
Secondary school graduate 3 (5.9)
High school graduate 1 (2.0)
University graduate 1 (2.0)
Marital status
Married 42 (82.4)
Single 3 (5.9)
Divorced 6 (11.8)
Disease duration (year) 14.91 ± 9.41
Morning stiffness period (min) 74.01 ± 65.45
Drugs used
NSAID 51 (100)
Sulfasalazine 39 (76.5)
Methotrexate 42 (82.4)
Leﬂunomide 12 (23.5)
Hydroxychloroquine 14 (27.5)
QOL (0–100 mm) 59.21 ± 26.00
DAS-28 score 5.50 ± 1.36
RF (IU/mL) 109.19 ± 184.69
HAQ (0–3) 1.53  ± 0.68
Mobility level (AIMS-2) (0–10) 5.27 ± 2.25
Walking level (AIMS-2) (0–10) 6.77 ± 2.61
SD, standard deviation; min, minute; NSAID, non steroidal anti-
inﬂammatory drug; QOL, quality of life; DAS-28, disease activity
score-28; RF, rheumatoid factor; HAQ, health assessment question-
naire; AIMS-2, arthritis impact measurement Scale-2.discrimination sensation
The comparisons between general health status and foot
functionality evaluations in patients with and without sensory
deﬁcit and also in those with and without polyneuropathy are
shown in Table 3.
In patients with sensory deﬁcits, a statistically signiﬁ-
cant deterioration was detected in general health status and
foot functionality, including mobility and walking (p = 0.044,
p = 0.005, p = 0.006, respectively) when compared to patients
with a normal sensory evaluation.
There was no statistically signiﬁcant difference in terms of
general health status, mobility and walking functions when
patients with polyneuropathy were compared to patients
with normal electrophysiological ﬁndings (p = 0.871, p = 0.532,
p = 0.866, respectively).
Discussion
In patients with RA, several extra-articular systems, includ-
ing the nervous system, are involved, and more  commonly,
the peripheral nervous system, and these cases are reported
as entrapment neuropathies, mononeuropathies, and sensory
and sensorimotor axonal polyneuropathy.7 The incidence of
peripheral nervous system involvement in RA has been shown
in studies to range widely, from 18% to 75%.7–9,18–20 This wide
range can be attributed to the fact that in patients with-
out clinical neuropathy, subclinical peripheral nervous system
involvement is detected during electrophysiologic studies and
autopsies. In these patients, the mechanism of involvement
of the peripheral nervous system is explained by the inﬂam-
mation and immune complex-mediated injury of myelinated
nerve ﬁbers as well as soft tissue swelling, bone deformi-
ties, and mechanical compression due to nodules.9 Further,
comorbidities and the drugs used by these patients may cause
secondary involvement of the peripheral nervous system.7
In RA patients with foot deformity, there is a special focus
on entrapment neuropathies.21 In older studies, polyneuro-
pathy was often associated with the presence of vasculitis.22
However, more  recently, sensory-predominant polyneuro-
pathy has emerged as the most frequently reported peripheral
neuropathy in RA patients independent of vasculitis.21 Addi-
tionally, in some studies, a higher rate of polyneuropathy
has been observed in patients with RA compared to healthy
subjects.23,24
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Table 3 – Comparison between general health and foot function evaluation in patients with and without sensory deﬁcit
and with and without polyneuropathy.
General health level Mobility level Walking level
mean ± SD mean ± SD mean ± SD
Sensory examination
Normal sensation (n = 12) 0.18 ± 0.72a 3.75 ± 1.86a 4.33 ± 2.38a
Sensory deﬁcits (n = 39) 1.64 ± 0.64 5.74 ± 2.16 6.91 ± 2.68
Polyneuropathy
Normal electrophysiology (n = 24) 1.52 ± 0.62 5.06 ± 2.35 6.83 ± 2.45
Polyneuropathy (n = 27) 1.55 ± 0.76 5.46 ± 2.18 6.70 ± 2.82
SD, standard deviation.
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Some studies have investigated the presence of polyneu-
opathy in RA. Disease duration, disease activity and RF
ositivity have been reported to be associated with neuro-
athic involvement, but have shown no association with foot
eformities and joint damage.7,10,23 These results are in con-
ict with the studies reporting much more  foot deformity
evelopment in patients with long-term illness and high dis-
ase activity.14 Therefore, the primary purpose of this study
as to exclude entrapment neuropathies due to mechani-
al compression caused by foot deformity and to evaluate
he peripheral nervous system involvement, including pos-
ible polyneuropathy, using sensory examination as well as
lectrophysiological methods. According to the results of our
tudy, there was impairment in at least one of the sensory
xamination tests in 76.4% of patients. On electrophysiological
tudies, sensorimotor axonal neuropathy was found in 52.9%
f patients.
In our study, the presence of polyneuropathy in RA
atients was consistent with the rate of 18–90% reported in
he literature.18–20 In these studies, particularly in patients
ith over 2–5 years’ disease duration, observed polyneuro-
athy was associated with disease duration, RF positivity
nd disease activity, irrelevant of joint deformities and radio-
raphic damage. In our study, in accordance with reports
n the literature, patients had much longer duration of dis-
ase (13 years) and higher levels of disease activity and RF
evels.
In our study, disturbance in terms of polyneuropathy
etected by sensory evaluation tests was much greater than
he polyneuropathy (76.4%) detected by electrophysiological
tudies. To our knowledge, there is no study in the literature
valuating sensory tests in RA patients speciﬁcally. How-
ver, in RA patients with polyneuropathy, some studies used
ensory tests including superﬁcial touch, pain, heat, and vibra-
ion senses as well as electrophysiological assessment and
eported disturbance in the sensory evaluation tests.20,22,25,26
ne other study compared electrophysiological methods
nd sensory evaluation tests. However, the study conducted
jena et al.25 reported that 12% of patients who were
etermined normal electrophysiologically had small ﬁber
europathy.
Electrophysiological methods only examine the thick
yelinated ﬁbers, and do not show the dysfunction of
nmyelinated and thinly myelinated ﬁbers. In sensoryevaluation tests, superﬁcial touch, pain and temperature
senses are conducted with unmyelinated C and thinly
myelinated A delta ﬁbers, while vibration and two-point
discrimination tests are conducted with thick myelinated
A beta ﬁbers.27 In two studies in patients with diabetes
mellitus, a high correlation was reported between the vibra-
tion sense and electrophysiological methods, but it does
not reﬂect the involvement of small ﬁbers.28,29 In another
study comparing the electrophysiological methods and
sensory evaluation tests, with the clinical examination
of pain and heat senses, small ﬁber neuropathy can be
detected in electrophysiologically normal patients.30 This
may explain why more  disturbance was detected using
sensory examination tests than with the electrophysiological
methods in our study. Thus, we think that a limitation of
our study is not verifying the possible existence of small-
ﬁber neuropathy with a diagnostic procedure such as skin
biopsy.
However, another possible cause of this result may be
changes in foot sensitivity to two-point discrimination, touch,
pain, and temperature senses due to hyperkeratosis in abnor-
mal  regions due to foot deformities. Studies of the feet
in RA patients have reported altered pressure zones and
decreased sensory sensitivity when compared to healthy
subjects.31 Another limitation is that our study did not include
a quantitative gait analysis. Larger studies are needed in this
regard.
It was also found in this study that general health status
and foot functionality are worse in patients with sensory dis-
turbance than in patients with a normal sensory examination,
but there was no statistically signiﬁcant difference between
the patients with and without polyneuropathy according to
ENMG.
There are no studies in the literature evaluating the rela-
tionship between disturbance in sensory tests in RA patients
and general health status and foot functionality. Furthermore,
the results reported in studies of RA patients with polyneuro-
pathy are conﬂicting.20,27
In the study of Bayrak et al.27 polyneuropathy in RA
patients was associated with the general health status as
assessed by HAQ, and disability was much greater in patients
with polyneuropathy than in patients without polyneuro-
pathy. On the other hand, Agarwal et al.19 study with 108
patients reported no association between polyneuropathy and
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general health status assessed by HAQ. Unlike our study,
patients in those studies had a shorter duration of illness
(mean 5.5 years), and the study was performed in patients
without foot deformities. We believe that there is not neces-
sarily an electrophysiological abnormality in all patients with
sensory disturbances. The statistically signiﬁcant difference
between the patients with and without sensory disturb-
ance in terms of general health status and foot functionality
supports this prediction. As discussed above, sensory disturb-
ance overlaps with the possibility of the presence of small
ﬁber neuropathy; however, more  comprehensive studies are
needed.
Conclusion
Finally, sensory disturbance was detected in 76% of RA
patients with foot deformities with sensory evaluation
tests. Although those patients had electrophysiologically
detected polyneuropathy, this method should not be assessed
alone especially in terms of general health status and
foot functionality. Further, even if electrophysiological tests
are normal, it should be taken into consideration that
the presence of sensory dysfunction alone may lead to
severe disability in general health status and foot function-
ality when compared to patients with a normal sensory
examination.
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